The purpose of this FOA is to advance the treatment of Chronic Kidney Disease (CKD) through pilot studies that seek to optimize critical elements of a full-scale randomized control trial design. Various treatments to slow or reverse progression of CKD have been tested in small trials with limited numbers of participants, but there still remain questions of the optimum agent(s), target population, dosing, data collection, and appropriate outcomes. This FOA solicits applications from investigators willing to collaborate on the design and conduct of pilot studies that will better inform the design of a full-scale randomized, controlled clinical trial(s) in CKD.
As the School of Medicine may only submit 1 proposal for this opportunity, the Office of Research and Graduate Education has established an internal review process to determine which proposal(s) will move forward to the funding agency.
To apply for this funding opportunity, please email a 1-2 page letter of intent describing your proposed aims and approach, a list of all anticipated investigators, and a biosketch of the PI to RGE at email@example.com by Tuesday, October 9, 2012. Applicants will be notified as soon as a decision is reached.
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at firstname.lastname@example.org.